In summary, our data demonstrate that FGFR3-IIIc exerts oncogenic effects in colorectal cancer cells by promoting in vitro tumour cell growth, survival, migration and responsiveness to oncogenic FGF ligands such as FGF18. The gene discussed is FGFR3; the disease is neoplasm.